Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study without detailed documentation
Remarks:
This study is included in a NONS registration and therefore has been evaluated by a relevant competent authority and is considered to be reliable.

Data source

Reference
Reference Type:
other: Body responsible for the test
Title:
Unnamed
Year:
2005

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: Annex V
GLP compliance:
yes
Type of assay:
mammalian bone marrow chromosome aberration test

Test material

Constituent 1
Chemical structure
Reference substance name:
3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea
EC Number:
406-690-3
EC Name:
3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea
Cas Number:
43136-14-7
Molecular formula:
C51H88N4O2
IUPAC Name:
3-octadecyl-1-[4-({4-[(octadecylcarbamoyl)amino]phenyl}methyl)phenyl]urea
Test material form:
solid: particulate/powder

Test animals

Species:
mouse
Strain:
NMRI
Sex:
male/female

Administration / exposure

Route of administration:
other: oral (not specified)
Vehicle:
- Vehicle(s)/solvent(s) used: corn oil
Duration of treatment / exposure:
24, 48 and 72 hours
Doses / concentrations
Dose / conc.:
5 000 mg/kg bw/day (nominal)
No. of animals per sex per dose:
5 per sex per dose
Control animals:
not specified
Positive control(s):
Not specified

Results and discussion

Test results
Key result
Sex:
male/female
Genotoxicity:
negative
Toxicity:
no effects
Remarks:
Based on P/N ratio
Additional information on results:
Other toxic signs: Dosing at 5000 mg/kg in a preliminary test for toxicity using 20 mL/kg b.w. resulted in a reduction in activity in all animals up to 6 hours post-dosing but these effects are not clearly substance related. No signs of toxicity were stated for the main study.

Applicant's summary and conclusion

Conclusions:
The test item was concluded to be negative for mammalian chromosome aberration. No signs of toxicity or cytotoxicity (based on P/N ratio) were observed.
Executive summary:

The test item was investigated for in vivo chromosome aberration in male and female NMRI mice following EU Annex V guidelines (micronucleus test). Test animals were administered 5000 mg/kg test item by oral gavage and sacrificed at 24, 48 and 72 hours. The test item was concluded to be negative for mammalian chromosome aberration. No signs of toxicity or cytotoxicity (based on P/N ratio) were observed.

The study is a GLP compliant, guideline experimental study and is acceptable with restrictions for assessment of this endpoint.